# Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

> **NCT00092937** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 2 (actual)

## Conditions studied

- Granulomatous Disease
- Chronic

## Interventions

- **DRUG:** Busulfan

## Key facts

- **NCT ID:** NCT00092937
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-23
- **Primary completion:** 2010-04-06
- **Final completion:** 2010-04-06
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092937, "Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00092937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*